Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
暂无分享,去创建一个
Anthony Trela | S. Seki | K. Nadeau | A. Mehrotra | E. Hoyte | R. Hamilton | P. Bégin | Morvarid Tavassoli | T. Dominguez | S. Wilson | L. Bacal | B. Kausch | G. O’Riordan | A. Blakemore | Scott M. Seki | Anthony V Trela | Elisabeth G. Hoyte | Anthony V. Trela